DAVID REAVIS: Open Payments
NPI 1306005681 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,554 in 22 payments from 6 companies in 2025. Trend: 2023 $574 · 2024 $753 · 2025 $1,554
Travel & lodging: $958Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 17 | $1,396 |
| Bioventus LLC | 1 | $50 |
| Averitas Pharma Inc. | 1 | $36 |
| Merz Pharmaceuticals, LLC | 1 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
Products named: PROCLAIM, DUROLANE, QUTENZA, Xeomin, JOURNAVX, BOTOX.
Industry payments across OR — which companies pay providers there.
